Tapewire

Nasdaq · USD

IVVD

Invivyd, Inc.

Export transactions ↓
Tapewire entity
721
SEC CIK
0001832038
Parsed reports
165

Last 12 months

Inside the activity.

1 purchase rows · 20 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 2026010
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026010
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 31, 2026 Filed Sep 2, 2026 20:40 UTC GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $0.95 $0.00
Disclosure

SEC source: 0001193125-26-380337 · ownership.xml · derivative · entry 1

Sheffield Ian · CIK 0001594410 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-08-30

F1 · derivative.exercise_date: This option was granted on August 31, 2026 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the total shares subject to the grant vesting in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
August 30, 2026 Filed Sep 1, 2026 22:30 UTC
Elia MarcDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 10,700,000 $0.00 Strike: $0.96 $0.00
Disclosure

SEC source: 0001193125-26-378862 · ownership.xml · derivative · entry 1

Elia Marc · CIK 0001830496 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,700,000

Underlying: Common Stock · 10,700,000 shares

Expires 2036-08-29

F1 · derivative.exercise_date: This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of August 30, 2026 and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 00:10 UTC
Lee Timothy EdwardChief Commercial Officer
SaleCommon Stock 18,425 $0.84 $15,530.43
Disclosure

SEC source: 0001193125-26-355915 · ownership.xml · nonDerivative · entry 3

Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,937

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 00:10 UTC
Green JulieChief Human Resources Officer
SaleCommon Stock 18,425 $0.84 $15,530.43
Disclosure

SEC source: 0001193125-26-355914 · ownership.xml · nonDerivative · entry 3

Green Julie · CIK 0002008797 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,937

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 00:10 UTC
Duke William E.Chief Financial Officer
SaleCommon Stock 18,425 $0.84 $15,530.43
Disclosure

SEC source: 0001193125-26-355913 · ownership.xml · nonDerivative · entry 3

Duke William E. · CIK 0001636135 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,937

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 00:10 UTC
Andersen JillChief Legal Officer, Secretary
SaleCommon Stock 30,706 $0.84 $25,882.09
Disclosure

SEC source: 0001193125-26-355912 · ownership.xml · nonDerivative · entry 3

Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 283,774

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
August 18, 2026 Filed Aug 19, 2026 00:10 UTC
Allen Robert D. IIIChief Scientific Officer
SaleCommon Stock 17,043 $0.84 $14,365.54
Disclosure

SEC source: 0001193125-26-355911 · ownership.xml · nonDerivative · entry 3

Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 178,765

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 00:10 UTC
Lee Timothy EdwardChief Commercial Officer
SaleCommon Stock 22,355 $0.72 $16,140.31
Disclosure

SEC source: 0001193125-26-355915 · ownership.xml · nonDerivative · entry 2

Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 197,362

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 00:10 UTC
Green JulieChief Human Resources Officer
SaleCommon Stock 22,355 $0.72 $16,140.31
Disclosure

SEC source: 0001193125-26-355914 · ownership.xml · nonDerivative · entry 2

Green Julie · CIK 0002008797 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,362

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 00:10 UTC
Duke William E.Chief Financial Officer
SaleCommon Stock 22,355 $0.72 $16,140.31
Disclosure

SEC source: 0001193125-26-355913 · ownership.xml · nonDerivative · entry 2

Duke William E. · CIK 0001636135 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 187,362

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 00:10 UTC
Andersen JillChief Legal Officer, Secretary
SaleCommon Stock 37,256 $0.72 $26,898.83
Disclosure

SEC source: 0001193125-26-355912 · ownership.xml · nonDerivative · entry 2

Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 314,480

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
August 17, 2026 Filed Aug 19, 2026 00:10 UTC
Allen Robert D. IIIChief Scientific Officer
SaleCommon Stock 20,679 $0.72 $14,930.24
Disclosure

SEC source: 0001193125-26-355911 · ownership.xml · nonDerivative · entry 2

Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 195,808

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Lee Timothy EdwardChief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 102,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-355915 · ownership.xml · derivative · entry 4

Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 102,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Lee Timothy EdwardChief Commercial Officer
Exercise / conversionCommon Stock 102,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-355915 · ownership.xml · nonDerivative · entry 1

Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 219,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Green JulieChief Human Resources Officer
Exercise / conversionRestricted Stock Units · Derivative 102,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-355914 · ownership.xml · derivative · entry 4

Green Julie · CIK 0002008797 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 102,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Green JulieChief Human Resources Officer
Exercise / conversionCommon Stock 102,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-355914 · ownership.xml · nonDerivative · entry 1

Green Julie · CIK 0002008797 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 209,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Duke William E.Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 102,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-355913 · ownership.xml · derivative · entry 4

Duke William E. · CIK 0001636135 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 102,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Duke William E.Chief Financial Officer
Exercise / conversionCommon Stock 102,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-355913 · ownership.xml · nonDerivative · entry 1

Duke William E. · CIK 0001636135 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 209,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Andersen JillChief Legal Officer, Secretary
Exercise / conversionRestricted Stock Units · Derivative 170,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-355912 · ownership.xml · derivative · entry 5

Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 170,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Andersen JillChief Legal Officer, Secretary
Exercise / conversionCommon Stock 170,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-355912 · ownership.xml · nonDerivative · entry 1

Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 351,736

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Allen Robert D. IIIChief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 102,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-355911 · ownership.xml · derivative · entry 4

Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 102,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
August 15, 2026 Filed Aug 19, 2026 00:10 UTC
Allen Robert D. IIIChief Scientific Officer
Exercise / conversionCommon Stock 102,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-355911 · ownership.xml · nonDerivative · entry 1

Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 216,487

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Read SEC document
July 31, 2026 Filed Aug 4, 2026 20:15 UTC
Mina MichaelCMO and Chief Epidemiologist
GrantStock Option (Right to Buy) · Derivative 1,125,000 $0.00 Strike: $0.54 $0.00
Disclosure

SEC source: 0001193125-26-332844 · ownership.xml · derivative · entry 1

Mina Michael · CIK 0001856954 · CMO and Chief Epidemiologist

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,125,000

Underlying: Common Stock · 1,125,000 shares

Expires 2036-07-30

F1 · derivative.exercise_date: This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of July 31, 2026 and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:47 UTC
Berry TamsinDirector
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0001193125-26-234656 · ownership.xml · derivative · entry 1

Berry Tamsin · CIK 0001924202 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-05-18

F1 · derivative.exercise_date: This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:48 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0001193125-26-234662 · ownership.xml · derivative · entry 1

MCGUIRE TERRANCE · CIK 0001117003 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-05-18

F1 · derivative.exercise_date: This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:49 UTC
Royan AjayDirector
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0001193125-26-234666 · ownership.xml · derivative · entry 1

Royan Ajay · CIK 0001875614 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-05-18

F1 · derivative.exercise_date: This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:48 UTC
Elia MarcDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0001193125-26-234661 · ownership.xml · derivative · entry 1

Elia Marc · CIK 0001830496 · Director · See Remarks

M28 Capital Management LP · CIK 0001807489 · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-05-18

F1 · derivative.exercise_date: This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date. The grant was awarded to Marc Elia ("Mr. Elia"). Mr. Elia is deemed to hold the grant for the benefit of M28 Capital Management LP ("M28 Capital Management") and the funds managed by M28 Capital Management.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:48 UTC
BOLNO PAULDirector
GrantStock Option (Right to Buy) · Derivative 32,876 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0001193125-26-234660 · ownership.xml · derivative · entry 1

BOLNO PAUL · CIK 0001657710 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,876

Underlying: Common Stock · 32,876 shares

Expires 2036-05-18

F1 · derivative.exercise_date: This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
May 19, 2026 Filed May 21, 2026 20:49 UTC GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0001193125-26-234665 · ownership.xml · derivative · entry 1

MCLAUGHLIN KEVIN F · CIK 0001214938 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-05-18

F1 · derivative.exercise_date: This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 01:47 UTC
Lee Timothy EdwardChief Commercial Officer
SaleCommon Stock 20,964 $1.58 $33,077.00
Disclosure

SEC source: 0001193125-26-057815 · ownership.xml · nonDerivative · entry 3

Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,717

F3 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 01:51 UTC
Green JulieChief Human Resources Officer
SaleCommon Stock 20,964 $1.58 $33,077.00
Disclosure

SEC source: 0001193125-26-057822 · ownership.xml · nonDerivative · entry 3

Green Julie · CIK 0002008797 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,717

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 01:49 UTC
Duke William E.Chief Financial Officer
SaleCommon Stock 20,964 $1.58 $33,077.00
Disclosure

SEC source: 0001193125-26-057819 · ownership.xml · nonDerivative · entry 3

Duke William E. · CIK 0001636135 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,717

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 01:56 UTC
Allen Robert D. IIIChief Scientific Officer
SaleCommon Stock 19,392 $1.58 $30,596.70
Disclosure

SEC source: 0001193125-26-057828 · ownership.xml · nonDerivative · entry 3

Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,487

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 01:47 UTC
Andersen JillChief Legal Officer, Secretary
SaleCommon Stock 34,939 $1.58 $55,126.75
Disclosure

SEC source: 0001193125-26-057814 · ownership.xml · nonDerivative · entry 3

Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 181,736

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.550 to $1.595, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:47 UTC
Lee Timothy EdwardChief Commercial Officer
SaleCommon Stock 19,663 $1.54 $30,273.15
Disclosure

SEC source: 0001193125-26-057815 · ownership.xml · nonDerivative · entry 2

Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,681

F3 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:51 UTC
Green JulieChief Human Resources Officer
SaleCommon Stock 19,663 $1.54 $30,273.15
Disclosure

SEC source: 0001193125-26-057822 · ownership.xml · nonDerivative · entry 2

Green Julie · CIK 0002008797 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,681

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:49 UTC
Duke William E.Chief Financial Officer
SaleCommon Stock 19,663 $1.54 $30,273.15
Disclosure

SEC source: 0001193125-26-057819 · ownership.xml · nonDerivative · entry 2

Duke William E. · CIK 0001636135 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,681

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:56 UTC
Allen Robert D. IIIChief Scientific Officer
SaleCommon Stock 18,189 $1.54 $28,003.78
Disclosure

SEC source: 0001193125-26-057828 · ownership.xml · nonDerivative · entry 2

Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,879

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 01:47 UTC
Andersen JillChief Legal Officer, Secretary
SaleCommon Stock 32,771 $1.54 $50,454.23
Disclosure

SEC source: 0001193125-26-057814 · ownership.xml · nonDerivative · entry 2

Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 216,675

F2 · shares: The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.505 to $1.590, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:47 UTC
Lee Timothy EdwardChief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 99,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-057815 · ownership.xml · derivative · entry 4

Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,000

Underlying: Common Stock · 99,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F6 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F6 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:47 UTC
Lee Timothy EdwardChief Commercial Officer
Exercise / conversionCommon Stock 99,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-057815 · ownership.xml · nonDerivative · entry 1

Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 158,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F2 · balance_after: The reported ownership includes 10,000 shares of common stock acquired through the Company's Employee Stock Purchase Program.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:51 UTC
Green JulieChief Human Resources Officer
Exercise / conversionRestricted Stock Units · Derivative 99,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-057822 · ownership.xml · derivative · entry 4

Green Julie · CIK 0002008797 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,000

Underlying: Common Stock · 99,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:51 UTC
Green JulieChief Human Resources Officer
Exercise / conversionCommon Stock 99,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-057822 · ownership.xml · nonDerivative · entry 1

Green Julie · CIK 0002008797 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:49 UTC
Duke William E.Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 99,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-057819 · ownership.xml · derivative · entry 4

Duke William E. · CIK 0001636135 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,000

Underlying: Common Stock · 99,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:49 UTC
Duke William E.Chief Financial Officer
Exercise / conversionCommon Stock 99,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-057819 · ownership.xml · nonDerivative · entry 1

Duke William E. · CIK 0001636135 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,344

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:56 UTC
Allen Robert D. IIIChief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 99,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-057828 · ownership.xml · derivative · entry 4

Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,000

Underlying: Common Stock · 99,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:56 UTC
Allen Robert D. IIIChief Scientific Officer
Exercise / conversionCommon Stock 99,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-057828 · ownership.xml · nonDerivative · entry 1

Allen Robert D. III · CIK 0001972424 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 152,068

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:47 UTC
Andersen JillChief Legal Officer, Secretary
Exercise / conversionRestricted Stock Units · Derivative 165,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-057814 · ownership.xml · derivative · entry 5

Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 165,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

F5 · derivative.exercise_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

F5 · derivative.expiration_date: This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document
February 15, 2026 Filed Feb 19, 2026 01:47 UTC
Andersen JillChief Legal Officer, Secretary
Exercise / conversionCommon Stock 165,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001193125-26-057814 · ownership.xml · nonDerivative · entry 1

Andersen Jill · CIK 0001891047 · Chief Legal Officer, Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 249,446

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").

Read SEC document
January 29, 2026 Filed Jan 30, 2026 21:16 UTC
Lee Timothy EdwardChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 675,000 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001193125-26-031840 · ownership.xml · derivative · entry 1

Lee Timothy Edward · CIK 0002025331 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 675,000

Underlying: Common Stock · 675,000 shares

Expires 2036-01-28

F1 · derivative.exercise_date: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date of January 29, 2026, subject to the Reporting Person's continuous service as of each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.